Skip to main content
Johannes Vieweg, MD, Urology, Fort Lauderdale, FL

JohannesWViewegMD

Urology Fort Lauderdale, FL

Infections & Inflammation, Surgical Oncology

Dean, College of Allopathic Medicine, Nova Southeastern University

Dr. Vieweg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Vieweg's full profile

Already have an account?

  • Office

    3200 S University Dr
    Suite 1506
    Fort Lauderdale, FL 33328
    Phone+1 954-262-1501

Summary

  • Dr. Vieweg has longstanding leadership and management expertise in diverse academic health, biomedical research and training environments. Since February 2016, Dr. Vieweg has served as the inaugural Dean of the College of Allopathic Medicine at Nova Southeastern University in Fort Lauderdale in Florida. The new school received accreditation in 2017 and enrolled students since 2018. His ambitious vision includes establishing a world-class medical school by creating new and innovative models of research, education and healthcare delivery, with a focus on improving health in Florida and beyond.

    Skill sets: Health management, Health administration, Health education, Urology, Biomedical research, Phase I/II clinical trials, Drug discovery, Regulatory drug management, Health policy, Global education, Health diplomacy, Health Crisis Management, Health Analytics

Education & Training

  • Duke University Hospital
    Duke University HospitalResidency, Surgery, 1994 - 1999
  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 1991 - 1993
  • Technical University Munich Faculty of Medicine
    Technical University Munich Faculty of MedicineClass of 1990
  • University of Regensburg, School of Medicine
    University of Regensburg, School of MedicineNo Degree, Pre-Med, 1982 - 1984

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2006 - 2025
  • NC State Medical License
    NC State Medical License 1993 - 2007
  • American Board of Urology Urology

Awards, Honors, & Recognition

  • Dr. Larry Zaroff Man of Good Conscience AMWA, 2019
  • Active Member American Association of Genitourinary Surgeons, 2012
  • The Wayne and Marti Eminent Scholar's Chair in Urologic Research University of Florida, 2008
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Calcium Oxalate Stone Fragment and Crystal Phagocytosis by Human Macrophages  
    Benjamin K Canales, Vincent G Bird, Johannes Vieweg, The Journal of Urology
  • Trifecta nerve complex: potential anatomical basis for microsurgical denervation of the spermatic cord for chronic orchialgia  
    Parekattil, S.J., Gudeloglu, A., Brahmbhatt, J.V., Prioloa, K.B., Vieweg, J., Allan, R.W, J Urol, 1/1/2013
  • Expansion of CCR8(+) inflammatory myeloid cells in cancer patients with urothelial and renal carcinomas  
    Eruslanov, E., Stoffs, T., Kim, W.J., Daurkin, I., Gilbert, S.M., Su, L.M., Vieweg, J., Daaka, Y., Kusmartsev, S, Clin Cancer Res, 1/1/2013
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Suppressing Immune Suppression
    Vieweg, J, American Association of Genitourinary Surgeons Annual Meeting, Amelia Island, FL, 1/24/2014
  • Update on Management of Advance Prostate Cancer
    Vieweg, J, International Society of Men’s Health and Academy of Family Physicians of Malaysia Joint Annual Meeting, Kuching, Malaysia, 1/23/2014
  • Update on Targeted Therapies for Advanced Renal Cell Carcinoma
    Vieweg, J, UF Department of Urology CME Conference, Orlando, FL, 1/22/2014
  • Join now to see all

Lectures

  • Advances in the Design and Clinical Implementations of Cancer Vaccines 
    Detroit, MI - 1/30/2011
  • Genetically Engineered Dendritic Cells for Immunologic Therapies of Urologic Cancers 
    Seattle, WA - 1/21/2011
  • What the AUA Means to Me 
    New Orleans, LA - 1/20/2011
  • Join now to see all

Other

  • Big Data in Biomedical Research 
    Vieweg, J, AUA News
    1/1/2014
  • The Evolution of NIDDK’s George M. O’Brien Research Centers Program 
    Vieweg, J, AUA News
    1/1/2013
  • Evaluating Research Quality 
    Vieweg, J, AUA News
    1/1/2013
  • Join now to see all

Press Mentions

  • Can’t Find a Doctor? Florida Facing Physician Shortage Amid Growth, Aging Population
    Can’t Find a Doctor? Florida Facing Physician Shortage Amid Growth, Aging PopulationMarch 16th, 2022
  • Business of Medicine: Is Concierge Medicine the Prescription for Doctors and Patients?
    Business of Medicine: Is Concierge Medicine the Prescription for Doctors and Patients?April 16th, 2021
  • Nova Southeastern Now Offers Two Paths to Medicine
    Nova Southeastern Now Offers Two Paths to MedicineMay 15th, 2019
  • Join now to see all

Grant Support

  • Ruth F. Kirstein T32 "Training Program in Urologic Research"NIDDK2011–Present
  • Elimination Of Immature Myeloid CellsNational Cancer Institute2006–2009
  • Matured, Renal Tumor Rna-Transfected Autologous Dendritic CellsNational Center For Research Resources2005
  • Active Immunotherapy Using Mature DC Transfected RNA Encoding HtertNational Center For Research Resources2005
  • Active Immunotherapy Using LAMP Htert RNA Transfected DC With Or Without DenileuNational Center For Research Resources2005
  • Telomerase RNA Transfected Dendritic Cell VaccinesNational Cancer Institute2002–2005
  • Matured, Renal Tumor Rna-Transfected Dendritic CellsNational Center For Research Resources2004
  • Immunotherapy Using Mature DC Transfected Htert RNANational Center For Research Resources2004
  • Elimination Of Regulatory T CellsNational Cancer Institute2003–2004
  • Immunotherapy With Renal Tumor RNA Transfected CellsNational Cancer Institute2001–2004
  • Immunotherapy Of Prostate Cancer With Tumor VaccinesNational Cancer Institute1999–2001
  • Phase I Safety &Feasibility Of Immunotherapy In Metastatic Prostate CarcinomaNational Center For Research Resources2000

Professional Memberships

Other Languages

  • German